GlassScriptPhysician profile
Melissa Siobhan Roe
NPI 1336510916
$3,020.49
in general payments reported to CMS, 2019-2025
16 companies · $701 in 2025
The $701 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $776 · 2022: $643 · 2023: $628 · 2024: $274 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.29 |
| Education | $399.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $621.25 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Leo Pharma INC. | $536.41 | 2021-2025 | Adbry, Anzupgo |
| Incyte Corporation | $329.67 | 2022-2025 | Opzelura |
| Abbvie INC. | $302.19 | 2021-2023 | |
| Lilly USA, LLC | $250.43 | 2021-2025 | Ebglyss |
| Regeneron Healthcare Solutions, INC. | $166.75 | 2021-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $153.13 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $149.13 | 2023 | Sotyktu |
| Pfizer INC. | $114.23 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Ucb, INC. | $84.07 | 2021-2024 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $81.04 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $57.56 | 2021-2022 | |
| Amgen INC. | $43.86 | 2021 | |
| Vyne Pharmaceuticals INC. | $16.58 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Roe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.